Metraipolis › archive › dc_bf31e7804d0c
SGLT2 inhibitors and diabetic retinopathy progression: evidence from a retrospective cohort study and Mendelian randomization analysis — Europe PMC PMID:42534740
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42534740
- DOI
- 10.3389/fendo.2026.1846454
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T06:21:28.303Z
- SHA-256 of the archived text
69410a3afddb5b099bc4f4f97016ca6236e8039340ca901b1ff6e25e4df50fec- Stable URL of this page
https://metraipolis.com/documento/dc_bf31e7804d0c
How to cite
SGLT2 inhibitors and diabetic retinopathy progression: evidence from a retrospective cohort study and Mendelian randomization analysis — Europe PMC PMID:42534740 — Europe PMC (en), https://europepmc.org/article/MED/42534740 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf31e7804d0c (Metraipolis archive dc_bf31e7804d0c, sha256 69410a3afddb5b099bc4f4f97016ca6236e8039340ca901b1ff6e25e4df50fec)
BibTeX
@misc{dcbf31e7804d0c,
title = {SGLT2 inhibitors and diabetic retinopathy progression: evidence from a retrospective cohort study and Mendelian randomization analysis — Europe PMC PMID:42534740},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42534740},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf31e7804d0c; sha256 69410a3afddb5b099bc4f4f97016ca6236e8039340ca901b1ff6e25e4df50fec},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42534740. Agents can read the archived copy with the MCP tool read_document.